These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9709380)

  • 1. In vitro test to determine the effect of cytostatic drugs on co-cultured rat hepatocytes and hepatoma cells.
    El-Mir MY; Serrano MA; Macias RI; Dominguez MF; Monte MJ; Marin JJ
    Int J Exp Pathol; 1998 Apr; 79(2):109-15. PubMed ID: 9709380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2.
    Marin JJ; Macias RI; Criado JJ; Bueno A; Monte MJ; Serrano MA
    Int J Cancer; 1998 Oct; 78(3):346-52. PubMed ID: 9766570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors.
    Monte MJ; Dominguez S; Palomero MF; Macias RI; Marin JJ
    J Hepatol; 1999 Sep; 31(3):521-8. PubMed ID: 10488713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zinc on rat hepatoma HTC cells and primary cultured rat hepatocytes.
    Steinebach OM; Wolterbeek HT
    Toxicol Appl Pharmacol; 1993 Feb; 118(2):245-54. PubMed ID: 8442003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of copper on rat hepatoma HTC cells and primary cultured rat hepatocytes.
    Steinebach OM; Wolterbeek HT
    J Inorg Biochem; 1994 Jan; 53(1):27-48. PubMed ID: 8133249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
    Herrera MC; Palomero MF; Macias RI; Serrano MA; Marin JJ
    Anticancer Res; 1998; 18(5A):3555-63. PubMed ID: 9858939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum (II).
    Marin JJ; Herrera MC; Palomero MF; Macias RI; Monte MJ; El-Mir MY; Villanueva GR
    J Hepatol; 1998 Mar; 28(3):417-25. PubMed ID: 9551679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between tumor cell load and sensitivity to the cytostatic effect of two novel platinum-bile acid complexes, Bamet-D3 and Bamet-UD2.
    Larena MG; Martinez-Diez MC; Macias RI; Dominguez MF; Serrano MA; Marin JJ
    J Drug Target; 2002 Aug; 10(5):397-404. PubMed ID: 12442810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
    Aizencang G; Harari P; Buldain G; Guerra L; Pickart M; Hernandez P; Frydman B
    Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):615-25. PubMed ID: 9678897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity.
    Larena MG; Martinez-Diez MC; Monte MJ; Dominguez MF; Pascual MJ; Marin JJ
    J Drug Target; 2001 Jun; 9(3):185-200. PubMed ID: 11697204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases.
    Vallejo M; Castro MA; Medarde M; Macias RI; Romero MR; El-Mir MY; Monte MJ; Briz O; Serrano MA; Marin JJ
    Biochem Pharmacol; 2007 May; 73(9):1394-404. PubMed ID: 17257589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
    Barbara C; Orlandi P; Bocci G; Fioravanti A; Di Paolo A; Natale G; Del Tacca M; Danesi R
    Eur J Pharmacol; 2006 Nov; 549(1-3):27-34. PubMed ID: 16978599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification.
    Briz O; Cassio D; Blazquez AG; Grosse B; Serrano MA; Marin JJ
    Toxicology; 2007 Mar; 232(1-2):24-36. PubMed ID: 17276572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
    Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
    Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
    Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
    Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and biotransformation of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver.
    Macias RI; Monte MJ; El-Mir MY; Villanueva GR; Marin JJ
    J Lipid Res; 1998 Sep; 39(9):1792-8. PubMed ID: 9741691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere dynamics determine episodes of anticancer drug resistance in rat hepatoma cells.
    Deschatrette J; Ng KH; Gouthière L; Maigné J; Guerroui S; Wolfrom C
    Anticancer Drugs; 2004 Aug; 15(7):671-8. PubMed ID: 15269598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo cisplatin resistance of rat ascites hepatoma AH66.
    Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
    Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.